338 related articles for article (PubMed ID: 8176894)
21. Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome.
Wei G; Zhihong L; Huiping C; Caihong Z; Zhaohong C; Leishi L
Nephrol Dial Transplant; 2006 Nov; 21(11):3146-54. PubMed ID: 16940319
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane.
Heikkilä P; Tibell A; Morita T; Chen Y; Wu G; Sado Y; Ninomiya Y; Pettersson E; Tryggvason K
Gene Ther; 2001 Jun; 8(11):882-90. PubMed ID: 11423936
[TBL] [Abstract][Full Text] [Related]
23. Alport syndrome with recurrent herpes simplex virus keratitis.
Chung PC; Lin KK; Song HS; Ku WC; Huang SC; Sun CC
Cornea; 2007 Dec; 26(10):1279-81. PubMed ID: 18043194
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural and immunofluorescence analysis of anterior lens capsules in autosomal recessive Alport syndrome.
Zhou J; Wu J; Yin Q; Yu X; Cui Y; Yang H; Shentu X
Ophthalmic Genet; 2021 Apr; 42(2):132-138. PubMed ID: 33251924
[No Abstract] [Full Text] [Related]
25. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
[TBL] [Abstract][Full Text] [Related]
26. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
27. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
28. [Anterior lenticonus: diagnostic aid in Alport syndrome].
Blaise P; Delanaye P; Martalo O; Pierard GE; Rorive G; Galand A
J Fr Ophtalmol; 2003 Dec; 26(10):1075-82. PubMed ID: 14691404
[TBL] [Abstract][Full Text] [Related]
29. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
30. Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.
Dehan P; Waltregny D; Beschin A; Noel A; Castronovo V; Tryggvason K; De Leval J; Foidart JM
Am J Pathol; 1997 Oct; 151(4):1097-104. PubMed ID: 9327743
[TBL] [Abstract][Full Text] [Related]
31. [Collagen alpha5 and alpha2 (IV) chain coexpression: The procedure of choice to diagnose Alport syndrome from skin biopsies].
Patey-Mariaud de Serre N; Noël LH
Ann Pathol; 2008 Jun; 28(3):182-6. PubMed ID: 18706356
[TBL] [Abstract][Full Text] [Related]
32. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
33. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution.
Gubler MC; Knebelmann B; Beziau A; Broyer M; Pirson Y; Haddoum F; Kleppel MM; Antignac C
Kidney Int; 1995 Apr; 47(4):1142-7. PubMed ID: 7783412
[TBL] [Abstract][Full Text] [Related]
34. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.
Mochizuki T; Lemmink HH; Mariyama M; Antignac C; Gubler MC; Pirson Y; Verellen-Dumoulin C; Chan B; Schröder CH; Smeets HJ
Nat Genet; 1994 Sep; 8(1):77-81. PubMed ID: 7987396
[TBL] [Abstract][Full Text] [Related]
35. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.
Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M
J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760
[TBL] [Abstract][Full Text] [Related]
36. Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome.
Morello R; Zhou G; Dreyer SD; Harvey SJ; Ninomiya Y; Thorner PS; Miner JH; Cole W; Winterpacht A; Zabel B; Oberg KC; Lee B
Nat Genet; 2001 Feb; 27(2):205-8. PubMed ID: 11175791
[TBL] [Abstract][Full Text] [Related]
37. Expression of novel basement membrane components in the developing human kidney and eye.
Kleppel MM; Michael AF
Am J Anat; 1990 Feb; 187(2):165-74. PubMed ID: 2301276
[TBL] [Abstract][Full Text] [Related]
38. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
[TBL] [Abstract][Full Text] [Related]
39. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG
Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274
[TBL] [Abstract][Full Text] [Related]
40. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
